See more : BNK Financial Group Inc. (138930.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Apexigen, Inc. (APGNW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Apexigen, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Chesswood Group Limited (CHWWF) Income Statement Analysis – Financial Results
- Easy Field Corporation (6425.TWO) Income Statement Analysis – Financial Results
- Vintage Wine Estates, Inc. (VWEWW) Income Statement Analysis – Financial Results
- BioLASCO Taiwan Co., Ltd. (6662.TWO) Income Statement Analysis – Financial Results
- Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) Income Statement Analysis – Financial Results
Apexigen, Inc. (APGNW)
Industry: Biotechnology
Sector: Healthcare
| Metric | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 23.04M | 21.66M | 18.77M |
| General & Administrative | 9.65M | 7.29M | 5.77M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 9.65M | 7.29M | 5.77M |
| Other Expenses | 617.00K | 0.00 | 0.00 |
| Operating Expenses | 32.69M | 28.96M | 24.54M |
| Cost & Expenses | 32.69M | 28.96M | 24.54M |
| Interest Income | 0.00 | 41.00K | 421.00K |
| Interest Expense | -617.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 110.00K | 105.00K | 127.00K |
| EBITDA | -32.58M | -28.85M | -24.42M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -32.69M | -28.96M | -24.54M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 617.00K | 41.00K | 421.00K |
| Income Before Tax | -32.07M | -28.92M | -24.12M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -617.00K | -41.00K | -421.00K |
| Net Income | -31.45M | -28.88M | -23.70M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | -1.59 | -0.93 | -0.76 |
| EPS Diluted | -1.59 | -0.93 | -0.76 |
| Weighted Avg Shares Out | 19.79M | 31.07M | 31.07M |
| Weighted Avg Shares Out (Dil) | 19.79M | 31.07M | 31.07M |
No news found for: APGNW
Source: https://incomestatements.info
Category: Stock Reports